CORONERY STENT XIENCE PRIME

The US FDA has approved Xience Prime, a next generation everolimus eluting coronary stent system for patients with coronary artery disease. According to Abbot Laboratories, this new stent offers doctors a wider range of drug eluting stents which have emanated from the SPIRIT family of trials. The company says that Xience Prime has an improved stent design and a more flexible delivery system compared to the Xience V® Everolimus Eluting Coronary Stent System. It also offers ideal radial strength and more accurate stent placement. The new stent uses the same drug and biocompatible polymer as the Xience V.


    Features:

  • Two registry arms were assessed:
    • The Core Size arm - Xience Prime stents were used, measuring 8mm to 28mm long and 2.25mm to 4mm in diameter.
    • The Long Lesion arm - Xience Prime stents were used, measuring either 33mm or 38mm long, and 2.5mm and 4mm in diameter.